Nephrology confers present on-going study and progressions in diagnosis as well as management of kidney related syndromes and associated epidemiology, molecular genetics, and pathophysiology. Generally nephrology is the study of kidney functionalities and its related problems.  The protection of kidney health and the cure of kidney problems, from diet as well as medication to renal replacement therapy (dialysis and kidney replacement) can also deal by in nephrology. Chronic kidney disease is a significant prognostic factor for cardiovascular disease as well as mortality in usual population. As the number of adults with chronic kidney disease are raising and is anticipating reaching over 600 million populations in the upcoming future. Additionally, the last stage of kidney failure was estimated to affect more than 2.6 million people whole over the world and is expecting to be double by 2030.

Conversely risk valuation in chronic kidney disease is stratified by the proteinuria as well as assessed glomerular filtration rate. This technique is suggested in present clinical guidelines. Risk evolution techniques have been improved with ad hoc investigations of randomized controlled trials in patients. So, we introduced and authenticated a novel clinical prediction models for end stage kidney failure with the help of chronic kidney disease japan cohart study database which is comprised of representative nephrology clinical centre facilities in Japan.


Calvin Parker
Editorial Assistant
Journal of Nephrology and Urology